IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q2 2021 Holdings

Filed 2021-08-16 | 13 holdings | $71.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$59.7M3,399,03483.9%
Cytokinetics Incorporated(CYTK)COM23282W605$10.8M545,10115.2%
Kinnate Biopharma Inc.COM49705R105$225.2K9,671,6430.3%
Lyell Immunopharma, Inc.COM55083R104$215.7K13,282,1810.3%
Pharvaris N.V.(PHVS)COMN69605108$60.8K3,261,9260.1%
Quantum-Si Incorporated(QSI)COM CL A74765K105$54.7K4,463,6190.1%
Kura Oncology, Inc.(KURA)COM50127T109$38.6K1,849,9470.1%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$32.0K1,205,7980.0%
Relay Therapeutics, Inc.(RLAY)COM75943R102$20.4K556,3800.0%
Olema Pharmaceuticals, Inc.(OLMA)COM68062P106$9.6K342,0300.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$7.8K1,787,0940.0%
Decibel Therapeutics, Inc.COM24343R106$2.6K297,7110.0%
Tempest Therapeutics, Inc.(OVASUSD)COM87978U108$2.1K190,2120.0%